Jing Sun

Prof. Dr. Jing Sun


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JLJiaming Liu
Jiaming Liu
FWFangyan Wang
Fangyan Wang
SLSuzhi Liu
Suzhi Liu
JDJimei Du
Jimei Du
XHXuezhen Hu
Xuezhen Hu
JSJing Sun
Jing Sun

25 June 2020 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
JLJiaming Liu
Jiaming Liu
HLHaijun Li
Haijun Li
TGTianyu Gong
Tianyu Gong
WCWenyang Chen
Wenyang Chen
SMShiyin Mao
Shiyin Mao
JSJing Sun
Jing Sun

23 October 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
YLYi Ling
Yi Ling
TGTianyu Gong
Tianyu Gong
JZJunmei Zhang
Junmei Zhang
QGQilu Gu
Qilu Gu
XGXinxin Gao
Xinxin Gao
JSJing Sun
Jing Sun
Post-stroke cognitive impairment (PSCI) is a common neuropsychiatric complication of stroke. Mounting evidence has demonstrated a connection between gut microbiota (GM) and neuropsychiatric disease. Our previous study revealed the changes in the GM in a mouse model of vascular dementia. However, the characteristic GM of PSCI remains unclear. This study aimed to characterize the GM of PSCI and explored the potential of GM as PSCI biomarkers. A total of 93 patients with ischemic stroke were enrolled in this study. The patients were divided into two groups according to their MoCA scores 3 months after stroke onset. Clinical data and biological variables were recorded. GM composition was analyzed using 16S ribosomal RNA sequencing, and the characteristic GM was identified by linear discriminant analysis Effect Size (Lefse). Our results showed that Proteobacteria was highly increased in the PSCI group compared with the post-stroke non-cognitive impairment (PSNCI) group, the similar alterations were also observed at the class, order, family, and genus levels of Proteobacteria. After age adjustments, the abundance of Firmicutes, and its members, including Clostridia, Clostridiales, Lachnospiraceae, and Lachnospiraceae_other, were significantly decreased in the age-matched PSCI group compared with the PSNCI group. Besides, the GM was closely associated with MoCA scores and the risk factors for PSCI, including higher baseline National Institute of Health Stroke Scale score, higher homocysteine (Hcy) level, higher prevalence of stroke recurrence, leukoaraiosis, and brain atrophy. The KEGG results showed the enriched module for folding, sorting and degradation (chaperones and folding catalysts) and the decreased modules related to metabolisms of cofactors and vitamins, amino acid, and lipid in PSCI patients. A significant correlation was observed between PSCI and the abundance of Enterobacteriaceae after adjustments (P = 0.035). Moreover, the receiver operating characteristic (ROC) models based on the characteristic GM and Enterobacteriaceae could distinguish PSCI patients from PSNCI patients [area under the curve (AUC) = 0.840, 0.629, respectively]. Our findings demonstrated that the characteristic GM, especially Enterobacteriaceae, might have the ability to predict PSCI in post-stroke patients, which are expected to be used as clinical biomarkers of PSCI.

9 January 2024 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
JLJiaming Liu
Jiaming Liu
XLXinhuang Lv
Xinhuang Lv
TYTao Ye
Tao Ye
MZMing Zhao
Ming Zhao
ZCZhibo Chen
Zhibo Chen
JSJing Sun
Jing Sun
Parkinson's disease (PD) is intricately linked to abnormal gut microbiota, yet the specific microbiota influencing clinical outcomes remain poorly understood. Our study identified a deficiency in the microbiota genus Blautia and a reduction in fecal short-chain fatty acid (SCFA) butyrate level in PD patients compared to healthy controls. The abundance of Blautia correlated with the clinical severity of PD. Supplementation with butyrate-producing bacterium B. producta demonstrated neuroprotective effects, attenuating neuroinflammation and dopaminergic neuronal death in mice, consequently ameliorating motor dysfunction. A pivotal inflammatory signaling pathway, the RAS-related pathway, modulated by butyrate, emerged as a key mechanism inhibiting microglial activation in PD. The change of RAS-NF-κB pathway in PD patients was observed. Furthermore, B. producta-derived butyrate demonstrated the inhibition of microglial activation in PD through regulation of the RAS-NF-κB pathway. These findings elucidate the causal relationship between specific gut microbiota and PD, presenting a novel microbiota-based treatment perspective for PD.

4 October 2024 in iScience
Verified
Journal Article
Open access
XLXinhuang Lv
Xinhuang Lv
LZLu Zhan
Lu Zhan
TYTao Ye
Tao Ye
HXHuijia Xie
Huijia Xie
ZCZhibo Chen
Zhibo Chen
JSJing Sun
Jing Sun
Gut microbiota plays a crucial role in the pathogenesis of Alzheimer disease (AD). Here, we found that AD patients had significantly lower abundance of Agathobacter, which were negatively correlated with cognitive impairment. Animal experiments showed that Agathobacter rectalis (A. rectalis) supplementation increased beneficial commensal bacteria, significantly improved pathological damage, and suppressed microglial activation in APP/PS1 mice. We further demonstrated that butyric acid, a metabolite of A. rectalis, reduced microglial activation and pro-inflammatory factor production via Akt/ nuclear factor κB (NF-κB) signal pathway in vitro. Meanwhile, we revealed that A. rectalis effectively inhibited activation of microglia in the APP/PS1 mice by regulating Akt/ NF-κB pathway. This finding highlights the role of A. rectalis and its metabolite butyrate in mitigating neuroinflammation in AD by modulating the Akt/NF-κB pathway.

11 October 2021 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
JLJiaming Liu
Jiaming Liu
TYTao Ye
Tao Ye
YZYuhe Zhang
Yuhe Zhang
RZRui Zhang
Rui Zhang
YKYu Kong
Yu Kong
JSJing Sun
Jing Sun